The Wall Street Journal on Tuesday examined how "consumers are receiving a flood of safety information about the drugs they take -- so much that it risks scaring some people." According to the Journal, a recent "series of prescription medication scares" has prompted the media, consumer advocacy groups and FDA to release more information regarding the safety of prescription medications.
The Wall Street Journal examines GlaxoSmithKline's (GSK) plan to share its database of compounds that could treat tropical diseases. The initiative will test how well "open-source principles work for developing new drugs," the newsp... Read Post
St. Petersburg Times recently examined how since the Florida Medicaid program last year began requiring physicians to receive approval before prescribing antipsychotic drugs to children younger than age six, the number of prescripti... Read Post